Total Payments
$6,840
2024 Payments
$446.75
Companies
38
Transactions
408
Medicare Patients
1,897
Medicare Billing
$512,150
Payment Breakdown by Category
Food & Beverage$6,674 (97.6%)
Education$165.12 (2.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,674 | 403 | 97.6% |
| Education | $165.12 | 5 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,689 | 125 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $754.97 | 37 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $671.35 | 38 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $512.37 | 22 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $402.29 | 38 | $0 (2019) |
| Mylan Specialty L.P. | $328.75 | 18 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $313.57 | 17 | $0 (2024) |
| Merck Sharp & Dohme LLC | $220.45 | 14 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $216.28 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $212.46 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $446.75 | 23 | Mallinckrodt Hospital Products Inc. ($137.76) |
| 2023 | $1,135 | 47 | GlaxoSmithKline, LLC. ($267.98) |
| 2022 | $974.86 | 47 | GlaxoSmithKline, LLC. ($209.42) |
| 2021 | $988.57 | 49 | GlaxoSmithKline, LLC. ($218.15) |
| 2020 | $490.70 | 33 | GlaxoSmithKline, LLC. ($154.11) |
| 2019 | $770.81 | 61 | Mallinckrodt Enterprises LLC ($159.42) |
| 2018 | $871.01 | 67 | GlaxoSmithKline, LLC. ($340.95) |
| 2017 | $1,162 | 81 | GlaxoSmithKline, LLC. ($283.38) |
All Payment Transactions
408 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: NEUROLOGY | ||||||
| 11/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $36.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Pulmonology | ||||||
| 08/22/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: ANTIBIOTIC | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $37.20 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: ANTIBIOTIC | ||||||
| 05/13/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: IMMUNOLOGY | ||||||
| 05/13/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Cardiology | ||||||
| 04/30/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $0.88 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $4.24 | General |
| Category: IMMUNOLOGY | ||||||
| 04/22/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: ANTIBIOTIC | ||||||
| 04/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Respiratory | ||||||
| 02/02/2024 | Resmed Corp | AIRSENSE (Device) | Food and Beverage | Cash or cash equivalent | $17.44 | General |
| Category: Sleep | ||||||
| 01/18/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $30.04 | General |
| Category: NEUROLOGY | ||||||
| 01/11/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: Cardiology | ||||||
| 01/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: IMMUNOLOGY | ||||||
| 01/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: IMMUNOLOGY | ||||||
| 01/04/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/15/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $35.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 347 | 905 | $193,936 | $86,459 |
| 2022 | 5 | 409 | 1,340 | $299,717 | $131,330 |
| 2021 | 5 | 494 | 1,463 | $278,713 | $127,007 |
| 2020 | 8 | 647 | 1,885 | $359,700 | $167,354 |
Total Patients
1,897
Total Services
5,593
Medicare Billing
$512,150
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 106 | 360 | $147,600 | $59,641 | 40.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 139 | 416 | $24,544 | $15,929 | 64.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 76 | $8,208 | $4,679 | 57.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 28 | $8,484 | $3,780 | 44.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 25 | $5,100 | $2,429 | 47.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 123 | 579 | $237,390 | $99,263 | 41.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 169 | 601 | $35,459 | $18,156 | 51.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 89 | $9,612 | $4,967 | 51.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 40 | 43 | $8,772 | $4,570 | 52.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 28 | $8,484 | $4,374 | 51.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 118 | 480 | $196,800 | $84,580 | 43.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 212 | 791 | $46,669 | $24,105 | 51.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 73 | 78 | $15,912 | $8,325 | 52.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 35 | 36 | $10,908 | $5,567 | 51.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 56 | 78 | $8,424 | $4,431 | 52.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 168 | 640 | $262,400 | $115,879 | 44.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 260 | 981 | $57,879 | $31,300 | 54.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 67 | 73 | $14,892 | $7,848 | 52.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 69 | 108 | $11,664 | $6,349 | 54.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 34 | 34 | $10,302 | $5,590 | 54.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 19 | $2,071 | $246.38 | 11.9% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2020 | 18 | 18 | $252.00 | $76.80 | 30.5% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2020 | 12 | 12 | $240.00 | $64.18 | 26.7% |
About Dr. Robert Davis, M.D
Dr. Robert Davis, M.D is a Pulmonary Disease healthcare provider based in Petersburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164473146.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Davis, M.D has received a total of $6,840 in payments from pharmaceutical and medical device companies, with $446.75 received in 2024. These payments were reported across 408 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,674).
As a Medicare-enrolled provider, Davis has provided services to 1,897 Medicare beneficiaries, totaling 5,593 services with total Medicare billing of $512,150. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Petersburg, VA
- Active Since 05/13/2006
- Last Updated 07/07/2016
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1164473146
Products in Payments
- ACTHAR (Biological) $1,074
- TRELEGY ELLIPTA (Drug) $788.75
- NUCALA (Biological) $538.82
- NUZYRA (Drug) $512.37
- OPSUMIT (Drug) $418.86
- UPTRAVI (Drug) $249.21
- GLASSIA (Biological) $235.87
- Yupelri (Drug) $181.64
- ANORO (Drug) $176.50
- LONHALA MAGNAIR (Drug) $151.04
- STIOLTO RESPIMAT (Drug) $133.06
- Esbriet (Biological) $121.34
- PURIFIED CORTROPHIN GEL (Drug) $110.48
- ORENITRAM (Drug) $105.84
- BEVESPI AEROSPHERE (Drug) $97.75
- OPSUMIT MACITENTAN (Drug) $86.90
- BREO (Drug) $85.46
- INJECTAFER (Drug) $85.12
- ZERBAXA (Drug) $82.95
- YUPELRI (Drug) $73.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.